Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

Kristina Vermeersch,Maria Gabrovska,Joseph Aumann,Ingel K. Demedts,Jean-Louis Corhay,Eric Marchand,Hans Slabbynck,Christel Haenebalcke,Michiel Haerens,Shane Hanon,Paul Jordens,Rudi Peché,Antoine Fremault,Tine Lauwerier,Anja Delporte,Bert Vandenberk,Rik Willems,Stephanie Everaerts,Ann Belmans,Kris Bogaerts,Geert Verleden,Thierry Troosters,Vincent Ninane,Guy Brusselle,Wim Janssens

Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

2019

Rationale: Azithromycin prevents acute exacerbations of chronic obstructive pulmonary disease (AECOPDs); however, its value in the treatment of an AECOPD requiring hospitalization remains to be def...

Keywords:

Diabetes mellitus
Anesthesia
Acute chronic
Azithromycin
Placebo-controlled study
Disease
Medicine

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations